Genetic variation in caveolin-1 correlates with long-term pancreas transplant function

Area of Science:

• Transplantation immunology
• Genetics
• Endocrinology

Background:

• Pancreas transplantation is a vital treatment for type 1 diabetes, but long-term graft function varies.
• Identifying predictors of graft survival is crucial for improving patient outcomes.
• Caveolin-1 (Cav1) gene variants have been linked to kidney transplant success.

Purpose of the Study:

• To investigate the association between Caveolin-1 (Cav1) gene variations and long-term pancreas graft function.
• To determine if Cav1 genotype in donors or recipients predicts pancreas transplant survival.

Main Methods:

• Genotyping of 435 pancreas donors and 431 recipients for common Cav1 variations.
• Analysis of death-censored cumulative events using Kaplan-Meier and Cox regression.
• Multivariate Cox regression adjusted for donor and recipient transplant factors.

Main Results:

• The rs4730751 Cav1 variant did not correlate with long-term pancreas graft function.
• Donor rs3801995 TT genotype (p=0.009) and rs9920 CC/CT genotype (p=0.010) were associated with reduced long-term graft survival.
• Multivariate analysis confirmed rs3801995 (HR=1.83) and rs9920 (HR=1.63) as predictors of graft function.

Conclusions:

• Donor Caveolin-1 (Cav1) genotype is a potential predictor of long-term pancreas graft function.
• Specific Cav1 variants (rs3801995, rs9920) in donors correlate with reduced graft survival.
• Further studies are needed to validate these pilot findings in larger datasets.